Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for prochlorperazine submitted by Cosette Pharmaceuticals, Inc. under ANDA 040058.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • prochlorperazine (prochlorperazine)

Snippet

SUPPL AP for PROCHLORPERAZINE (PROCHLORPERAZINE)